Skip to content
healthcare.dev

Tirosint

NDC 71858-0035, levothyroxine sodium, capsule, from IBSA Pharma Inc..

Product NDC
71858-0035
Status
Listed
Labeler
IBSA Pharma Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021924
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71858-0035 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LEVOTHYROXINE SODIUM112 ug/1

Pharmacologic classes

Thyroxine [CS]; l-Thyroxine [EPC]

Package NDCNDC-11Package
71858-0035-2718580035023 BLISTER PACK in 1 CARTON (71858-0035-2) / 10 CAPSULE in 1 BLISTER PACK
71858-0035-4718580035043 BLISTER PACK in 1 CARTON (71858-0035-4) / 10 CAPSULE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7a7ade79-0165-4e31-b84e-667416c00c7e

Use it

Look up 71858-0035 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71858-0035 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71858-0035. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.